Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines.

MLA

Jackson, J. D., et al. “Assessment of Oncolytic HSV Efficacy Following Increased Entry-Receptor Expression in Malignant Peripheral Nerve Sheath Tumor Cell Lines.” Gene Therapy, vol. 21, no. 11, Nov. 2014, pp. 984–90. EBSCOhost, https://doi.org/10.1038/gt.2014.72.

APA

Jackson, J. D., McMorris, A. M., Roth, J. C., Coleman, J. M., Whitley, R. J., Gillespie, G. Y., Carroll, S. L., Markert, J. M., & Cassady, K. A. (2014). Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. Gene Therapy, 21(11), 984–990. https://doi.org/10.1038/gt.2014.72

Chicago

Jackson, J D, A M McMorris, J C Roth, J M Coleman, R J Whitley, G Y Gillespie, S L Carroll, J M Markert, and K A Cassady. 2014. “Assessment of Oncolytic HSV Efficacy Following Increased Entry-Receptor Expression in Malignant Peripheral Nerve Sheath Tumor Cell Lines.” Gene Therapy 21 (11): 984–90. doi:10.1038/gt.2014.72.